- Home
- VEON vs DAWN Comparison
VEON vs DAWN Comparison
Compare VEON & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEON
- DAWN
- Stock Information
- Founded
- VEON 1992
- DAWN 2018
- Country
- VEON Netherlands
- DAWN United States
- Employees
- VEON N/A
- DAWN N/A
- Industry
- VEON Telecommunications Equipment
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- VEON Telecommunications
- DAWN Health Care
- Exchange
- VEON Nasdaq
- DAWN Nasdaq
- Market Cap
- VEON 2.4B
- DAWN 1.3B
- IPO Year
- VEON 1996
- DAWN 2021
- Fundamental
- Price
- VEON $39.04
- DAWN $12.79
- Analyst Decision
- VEON Strong Buy
- DAWN Strong Buy
- Analyst Count
- VEON 1
- DAWN 7
- Target Price
- VEON $48.00
- DAWN $36.17
- AVG Volume (30 Days)
- VEON 75.3K
- DAWN 937.9K
- Earning Date
- VEON 11-14-2024
- DAWN 10-30-2024
- Dividend Yield
- VEON N/A
- DAWN N/A
- EPS Growth
- VEON N/A
- DAWN N/A
- EPS
- VEON N/A
- DAWN N/A
- Revenue
- VEON $3,955,000,000.00
- DAWN $101,953,000.00
- Revenue This Year
- VEON $12.10
- DAWN N/A
- Revenue Next Year
- VEON $7.27
- DAWN $36.10
- P/E Ratio
- VEON $4.35
- DAWN N/A
- Revenue Growth
- VEON 7.36
- DAWN N/A
- 52 Week Low
- VEON $18.50
- DAWN $11.94
- 52 Week High
- VEON $39.87
- DAWN $18.07
- Technical
- Relative Strength Index (RSI)
- VEON 74.32
- DAWN 39.97
- Support Level
- VEON $34.87
- DAWN $12.26
- Resistance Level
- VEON $36.86
- DAWN $12.81
- Average True Range (ATR)
- VEON 1.49
- DAWN 0.52
- MACD
- VEON 0.23
- DAWN -0.05
- Stochastic Oscillator
- VEON 86.28
- DAWN 28.94
About VEON VEON Ltd. ADS
VEON Ltd is a global provider of connectivity and internet services. The company provides its customers with voice, fixed broadband, data, and digital services. Currently, the company offers services to customers in the following countries: Pakistan, Ukraine, Kazakhstan, Bangladesh, Uzbekistan, and Kyrgyzstan. The reportable segments currently consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. The company provides services under the Beeline, Kyivstar, banglalink and Jazz brands.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.